Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1456 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Depomed gets Michael J Fox Foundation grant

The tablet targets constant blood levels of levodopa compared to current therapy while reducing dosing frequency and maintaining effectiveness in controlling Parkinson’s symptoms. Depomed said that the two

Pfizer to acquire King Pharma

King’s three key businesses are not only complementary to Pfizer’s businesses, but are also strategically aligned with Pfizer’s Primary Care, Established Products and Animal Health business units, enabling

Denosumab proves superior over Zometa: Amgen

Reportedly, Zometa (zoledronic acid) is the current standard of care in the prevention of SREs in patients with advanced malignancies involving bone. Amgen said that the effect of